The World Health Organization (WHO) has been making headlines lately, and that’s due to the fact that the world is dealing with COVID-19. It’s also in large part due to the fact that that President Donald Trump recently halted all funding to the WHO from the US. He accused the organization of “severely mismanaging and covering up the spread of the coronavirus.” This implies, in my opinion, that they were covering up the spread based on the fact they (the WHO) would somehow profit, financially and politically from the pandemic.
Wikileaks recently posted about the WHO on their social media accounts, and they did so in the form of confidential documents they released nearly a decade ago highlighting the influence that big pharmaceutical companies have over the WHO. As Wikileaks states,
The compilation of documents shows the influence of “Big Pharma” on the policy making decisions of the WHO, the UN body safeguarding public health. These confidential documents were obtained by the drug industry before their public release to WHO member states. The document also illustrates that the WHO expert group was highly responsive to industry lobbying — a result that public health groups had feared since early 2009, when the expert group met with the industry, but refused to meet with public health groups known to be industry critics. The likely audience for these documents include countries, public health policy makers, civil society, industry, academia, media, patients and the general public. (source)
If you a want to read the documents, you can access them here.
The relationship between the WHO and pharmaceutical companies isn’t really highlighted in the mainstream at all, and therefore it’s off the radar and not on the minds of the masses. We see the same type of thing when it comes to ‘big pharma’ and its relationship between our federal health regulatory agencies. Despite the fact that these relationships and examples of corruption aren’t highlighted by mainstream media, they are and have been highlighted for many years.